Format
Sort by
Items per page

Send to

Choose Destination

Best matches for fibrodysplasia ossificans progressiva:

Neofunction of ACVR1 in fibrodysplasia ossificans progressiva. Hino K et al. Proc Natl Acad Sci U S A. (2015)

Fibrodysplasia ossificans progressiva: diagnosis, management, and therapeutic horizons. Pignolo RJ et al. Pediatr Endocrinol Rev. (2013)

Is "fibrodysplasia ossificans progressiva" a vascular disease? A groundbreaking pathogenic model. Morales-Piga A et al. Reumatol Clin. (2014)

Search results

Items: 1 to 20 of 2399

1.

[Myositis ossificans progressia of lateral pterygoid muscle of both sides: a case report].

Lin N, Gao N, He W.

Zhonghua Kou Qiang Yi Xue Za Zhi. 2018 Jul 9;53(7):488-489. doi: 10.3760/cma.j.issn.1002-0098.2018.07.013. Chinese. No abstract available.

PMID:
29996370
2.

Fibrodysplasia Ossificans Progressiva: A Case Report.

Acharya S, Joshi S, Chaulagain R.

J Nepal Health Res Counc. 2018 Jul 4;16(2):245-247.

PMID:
29983445
3.

COL1A1 is a fusionpartner of USP6 in myositis ossificans - FISH analysis of six cases.

Flucke U, Bekers EM, Creytens D, van Gorp JM.

Ann Diagn Pathol. 2018 Jun 30. pii: S1092-9134(18)30208-9. doi: 10.1016/j.anndiagpath.2018.06.009. [Epub ahead of print] No abstract available.

PMID:
29980413
4.

Ankylosing Neurogenic Myositis Ossificans of the Hip: A Case Series and Review of Literature.

Yoon BH, Park IK, Sung YB.

Hip Pelvis. 2018 Jun;30(2):86-91. doi: 10.5371/hp.2018.30.2.86. Epub 2018 Jun 4.

5.

Bone Resection Osteotomy in Fibrodysplasia Ossificans Progressiva.

Colmenares-Bonilla D, Gonzalez-Segoviano A.

J Orthop Case Rep. 2018 Jan-Feb;8(1):39-43. doi: 10.13107/jocr.2250-0685.990.

6.

Pseudomalignant myositis ossificans in the breast: A case report.

Pohlodek K, Janík M, Mečiarová I, Ondriaš F.

Mol Clin Oncol. 2018 Jun;8(6):749-752. doi: 10.3892/mco.2018.1609. Epub 2018 Apr 13.

7.

[Effect of functional exercise at different time and different immobilization positions on functional recovery of elbow joint with type C distal humeral fractures].

Li H, Wang Y, Che Z, Gou Y, Xu L, Lu B.

Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2017 Aug 1;31(8):946-951. doi: 10.7507/1002-1892.201701021. Chinese.

PMID:
29806431
8.

Fibro-osseous pseudotumor of digits - Expanding the spectrum of clonal transient neoplasms harboring USP6 rearrangement.

Flucke U, Shepard SJ, Bekers EM, Tirabosco R, van Diest PJ, Creytens D, van Gorp JM.

Ann Diagn Pathol. 2018 May 12;35:53-55. doi: 10.1016/j.anndiagpath.2018.05.003. [Epub ahead of print]

9.

Severe trismus and contraindicated exodontia in a patient with fibrodysplasia ossificans progressiva: case report.

Geddis-Regan A.

Br J Oral Maxillofac Surg. 2018 Jun;56(5):427-429. doi: 10.1016/j.bjoms.2018.03.021. Epub 2018 May 3.

PMID:
29730069
10.

Myositis Ossificans: Delayed Complication of Severe Muscle Contusion.

Rossettini G, Ristori D, Testa M.

J Orthop Sports Phys Ther. 2018 May;48(5):420. doi: 10.2519/jospt.2018.7567.

PMID:
29712545
11.

Myositis ossificans - Another condition with USP6 rearrangement, providing evidence of a relationship with nodular fasciitis and aneurysmal bone cyst.

Bekers EM, Eijkelenboom A, Grünberg K, Roverts RC, de Rooy JWJ, van der Geest ICM, van Gorp JM, Creytens D, Flucke U.

Ann Diagn Pathol. 2018 Jun;34:56-59. doi: 10.1016/j.anndiagpath.2018.01.006. Epub 2018 Jan 12.

12.

A Bizarre Bone Scan of Fibrodysplasia Ossificans Progressiva.

Chuang TL, Ho KW, Wang YF.

Clin Nucl Med. 2018 Jun;43(6):433-435. doi: 10.1097/RLU.0000000000002097.

PMID:
29659394
13.

Hypoxia-selective allosteric destabilization of activin receptor-like kinases: A potential therapeutic avenue for prophylaxis of heterotopic ossification.

Lu G, Tandang-Silvas MR, Dawson AC, Dawson TJ, Groppe JC.

Bone. 2018 Jul;112:71-89. doi: 10.1016/j.bone.2018.03.027. Epub 2018 Apr 5.

PMID:
29626545
15.

Acquired and congenital forms of heterotopic ossification: new pathogenic insights and therapeutic opportunities.

Pacifici M.

Curr Opin Pharmacol. 2018 Jun;40:51-58. doi: 10.1016/j.coph.2018.03.007. Epub 2018 Mar 31. Review.

PMID:
29614433
16.

Genetic defects in SAPK signalling, chromatin regulation, vesicle transport and CoA-related lipid metabolism are rescued by rapamycin in fission yeast.

Sajiki K, Tahara Y, Villar-Briones A, Pluskal T, Teruya T, Mori A, Hatanaka M, Ebe M, Nakamura T, Aoki K, Nakaseko Y, Yanagida M.

Open Biol. 2018 Mar;8(3). pii: 170261. doi: 10.1098/rsob.170261.

17.

The Horizon of a Therapy for Rare Genetic Diseases: A "Druggable" Future for Fibrodysplasia Ossificans Progressiva.

Cappato S, Giacopelli F, Ravazzolo R, Bocciardi R.

Int J Mol Sci. 2018 Mar 26;19(4). pii: E989. doi: 10.3390/ijms19040989. Review.

18.

Heterotopic Ossification: The Keys to the Kingdom.

Kaplan FS, Pignolo RJ, Shore EM.

Bone. 2018 Apr;109:1-2. doi: 10.1016/j.bone.2018.03.001. No abstract available.

PMID:
29567209
19.

Effects of FKBP12 and type II BMP receptors on signal transduction by ALK2 activating mutations associated with genetic disorders.

Machiya A, Tsukamoto S, Ohte S, Kuratani M, Fujimoto M, Kumagai K, Osawa K, Suda N, Bullock AN, Katagiri T.

Bone. 2018 Jun;111:101-108. doi: 10.1016/j.bone.2018.03.015. Epub 2018 Mar 15.

20.

Difficult diagnosis and genetic analysis of fibrodysplasia ossificans progressiva: a case report.

Tian S, Zhu J, Lu Y.

BMC Med Genet. 2018 Feb 27;19(1):30. doi: 10.1186/s12881-018-0543-7.

Supplemental Content

Loading ...
Support Center